SCHEMBL13846616

SCHEMBL13846616

CC1(C)c2cccnc2NC(=O)N1N

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 1/20 0.37
▸ NPC1 O15118 2/20 0.37
▸ CYP1A2 P05177 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ GAA P10253 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ MCL1 Q07820 1/20 0.33
▸ AR P10275 2/20 0.33
▸ AKR1B1 P15121 2/20 0.33
▸ OTUD7B Q6GQQ9 1/20 0.31
▸ RAF1 P04049 1/20 0.31
▸ NTRK1 P04629 1/20 0.31
▸ KCNH2 Q12809 2/20 0.31
▸ APP P05067 1/20 0.31
▸ SNCA P37840 1/20 0.31
▸ TNKS2 Q9H2K2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13068318 0.73 GSK3B (0.37) GSK3BNPC1CYP1A2SMN1; SMN2ALDH1A1
SCHEMBL24390000 0.72 NPC1 (0.45) GSK3BNPC1CYP1A2SMN1; SMN2ALDH1A1
SCHEMBL31404120 0.72 PDK2 (0.50) GSK3BNPC1CYP1A2SMN1; SMN2ALDH1A1
SCHEMBL2268820 0.72 PDK2 (0.50) GSK3BNPC1CYP1A2SMN1; SMN2ALDH1A1
SCHEMBL13907675 0.72 AKR1B1 (0.54) ALDH1A1GAAAKR1B1
Hydrochloric Acid SCHEMBL30775696 0.70 PDK2 (0.48) GSK3BNPC1CYP1A2SMN1; SMN2ALDH1A1
SCHEMBL13004676 0.70 NPC1 (0.46) GSK3BNPC1CYP1A2SMN1; SMN2ALDH1A1
SCHEMBL19664227 0.70 GSK3B (0.38) GSK3BNPC1CYP1A2SMN1; SMN2ALDH1A1
SCHEMBL24162546 0.69 GSK3B (0.37) GSK3BNPC1CYP1A2SMN1; SMN2ALDH1A1
SCHEMBL20808324 0.68 GSK3B (0.41) GSK3BNPC1CYP1A2SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009065921-A2 NOVEL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-05-28 — — WO disclosed
Send feedback